IMMUTEP LIMITED — Director's Dealing 2013

Apr 9, 2013

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of Entity: PRIMA BIOMED LIMITED (ASX:PRR) ACN:[90 009 237 889 ]

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Ms Lucy Turnbull Date of Last Notice: 04.04.2013

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Director related entity Turnbull and Partners PL
Date of change		10 April 2013
No. of securities held prior to change					Options 10,000,000 - 10,000,000
			Shares		Options
		Direct	4,347,076		10,000,000
		Indirect	475,000		-
		Total	4,822,076		10,000,000
Class		Fully paid ordinary shares
Number acquired					Options - - -
			Shares		Options
		Direct	-		-
		Indirect	250,000		-
		Total	250,000		-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

==> picture [419 x 236] intentionally omitted <==

----- Start of picture text -----

Number disposed
Shares Options
Direct - -
Indirect - -
Total - -
Value/Consideration
$22,750
Note: If consideration is non-cash, provide details and
estimated valuation
No. of securities held after change
Shares Options
Direct 4,347,076 10,000,000
Indirect 725,000 -
Total 5,072,076 10,000,000
Nature of change
Acquired 250,000 fully paid ordinary shares on
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment market at $0.091 each.
plan, participation in buy-back
----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 - +Closed Period

Were the interests in the securities or contracts detailed above traded No during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided on what date was this provided?

10.04.2013

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002